PAB is dangling atm - no deals signed, few patents achieved as far as I can tell (happy to be corrected) and just a promising hint that its latest creation is effective, yet to be proven. What do punters expect of a company in PAB's position? and remember there are a number of other bio's currently competing for the market dollar with probably just as good prospects.
4th patient group complete, page-36
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1853666 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3325244 | 5 |
View Market Depth
| Last trade - 13.46pm 16/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable